---
schema_version: "secwatch.filing_event.v1"
accession: "0001459839-23-000058"
form_type: "8-K"
ticker: "SIBN"
cik: "0001459839"
company_name: "SI-BONE, Inc."
filed_at: "2023-05-01T23:59:59+00:00"
generated_at: "2026-06-16T04:51:46.705901+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# SI-BONE Q1 revenue $32.7M (+46% YoY), raises FY2023 guidance to $128-131M

## Summary
- Record worldwide revenue $32.7M (+46% YoY); US revenue $30.5M (+50% YoY).
- Net loss improved to $11.1M ($0.32/diluted share) from $17.4M ($0.52) a year ago.
- Gross margin 82% (down from 87%) due to product mix, new implants, and higher freight/depreciation.
- FY2023 revenue guidance raised to $128-131M, implying 20-23% annual growth.
- Over 950 active US surgeons (+40% YoY); cash $86M, borrowings $35.9M.

## SEC filing metadata
- accession: 0001459839-23-000058
- form_type: 8-K
- ticker: SIBN
- cik: 0001459839
- company_name: SI-BONE, Inc.
- filed_at: 2023-05-01T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1459839/000145983923000058/0001459839-23-000058-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1459839/000145983923000058/sibn-20230501.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001459839-23-000058
- JSON: https://secwatch.observer/filing/0001459839-23-000058.json
- Plain text: https://secwatch.observer/filing/0001459839-23-000058.txt

## Key facts
- Earnings Releases
  SI-BONE, Inc. reported fiscal year 2023 results: revenue $128 million to $131 million. Guidance raised.
  - Period: fiscal year 2023
  - Revenue: $128 million to $131 million
  - Guidance: raised
  - Result: guidance update
  source text: SI-BONE is updating its 2023 worldwide revenue guidance to be in the range of $128 million to $131 million, implying growth of approximately 20% to 23%.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1459839/000145983923000058/0001459839-23-000058-index.htm
- Earnings Releases
  SI-BONE, Inc. reported the quarter ended March 31, 2023 results: revenue $32.7 million.
  - Period: the quarter ended March 31, 2023
  - Revenue: $32.7 million
  - Result: preliminary results
  source text: musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter ended March 31, 2023. Recent Highlights • Record world wide revenue of $32.7 million for the first quarter 2023, representing approximately 46% increase over the corresponding period in 2022 • Record U.S. revenue of $30.5 million for the first quarter 2023,
  evidence_url: https://www.sec.gov/Archives/edgar/data/1459839/000145983923000058/0001459839-23-000058-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.